Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
Knight Transportation
KNX
$11.1B
| $16M | ﹤0.01% |
306,700
-47,800
| -13% | -$2.24M |
|
2602
CALL
Praxis Precision Medicines
PRAX
$8.52B
| $16M | ﹤0.01% |
54,200
+29,900
| +123% | +$5.57M |
|
2603
CALL
Invesco
IVZ
$13.6B
| $16M | ﹤0.01% |
608,100
+283,800
| +88% | +$6.93M |
|
2604
PUT
FIVE9
FIVN
$2.22B
| $16M | ﹤0.01% |
796,400
+403,600
| +103% | +$8.57M |
|
2605
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$846M
| $15.9M | ﹤0.01% |
3,378,600
+539,800
| +19% | +$2.41M |
|
2606
Amplitude
AMPL
$1.26B
| $15.9M | ﹤0.01% |
1,376,002
+803,478
| +140% | +$8.45M |
|
2607
CALL
General Mills
GIS
$19.2B
| $15.9M | ﹤0.01% |
342,100
+61,800
| +22% | +$2.94M |
|
2608
CALL
SL Green Realty
SLG
$3.85B
| $15.9M | ﹤0.01% |
345,800
+53,100
| +18% | +$2.62M |
|
2609
Carlisle Companies
CSL
$14.8B
| $15.9M | ﹤0.01% |
49,589
-144,542
| -74% | -$46.8M |
|
|
ETOR
2610
eToro Group
ETOR
$2.9B
| $15.8M | ﹤0.01% |
450,083
+9,044
| +2% | +$349K |
|
2611
PUT
Lumen
LUMN
$6.65B
| $15.8M | ﹤0.01% |
2,034,500
-4,442,300
| -69% | -$36.6M |
|
2612
SiriusXM
SIRI
$10.2B
| $15.8M | ﹤0.01% |
790,308
-1,687,820
| -68% | -$36.3M |
|
2613
Garrett Motion
GTX
$5.71B
| $15.8M | ﹤0.01% |
905,781
-1,653,400
| -65% | -$26.3M |
|
2614
ResMed
RMD
$31.2B
| $15.8M | ﹤0.01% |
65,500
-127,094
| -66% | -$32.5M |
|
2615
Harmony Biosciences
HRMY
$2.06B
| $15.7M | ﹤0.01% |
420,410
+352,398
| +518% | +$11.6M |
|
|
LMRI
2616
Lumexa Imaging Holdings
LMRI
$1.08B
| $15.7M | ﹤0.01% |
+850,000
| New | +$15.3M |
|
2617
CALL
Bunge Global
BG
$20.2B
| $15.7M | ﹤0.01% |
176,500
-132,700
| -43% | -$12.2M |
|
2618
Core & Main
CNM
$8.56B
| $15.7M | ﹤0.01% |
+302,457
| New | +$15.5M |
|
2619
CALL
Cinemark Holdings
CNK
$4.39B
| $15.7M | ﹤0.01% |
675,900
-153,000
| -18% | -$4.02M |
|
2620
CALL
Pultegroup
PHM
$24.6B
| $15.7M | ﹤0.01% |
133,900
-57,000
| -30% | -$6.99M |
|
2621
PUT
Darden Restaurants
DRI
$23.6B
| $15.7M | ﹤0.01% |
85,300
-74,800
| -47% | -$13.6M |
|
2622
CALL
Texas Pacific Land
TPL
$28B
| $15.7M | ﹤0.01% |
54,600
-4,800
| -8% | -$1.47M |
|
|
OKLO
2623
Oklo
OKLO
$7.17B
| $15.7M | ﹤0.01% |
218,472
+96,511
| +79% | +$10.8M |
|
2624
Corning
GLW
$126B
| $15.7M | ﹤0.01% |
178,999
-287,616
| -62% | -$24.8M |
|
2625
CALL
abrdn Physical Silver Shares ETF
SIVR
$4.03B
| $15.6M | ﹤0.01% |
231,200
+188,300
| +439% | +$9.89M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.